Sales rise for blood-screening system kits, company reports

03/1/2012 | CBS MoneyWatch

Cerus reported it saw an increase in revenue in the fourth quarter due in part to higher sales of disposable kits used with its Intercept blood-screening system, which eliminates bacteria, viruses and parasites in donated platelets. The company said it is preparing to initiate two late-stage clinical trials involving its screening system for red blood cells.

View Full Article in:

CBS MoneyWatch

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA